DOI: 10.12890/2026_007603
Retinal drusen as an extra-renal manifestation of C3 glomerulopathy
Authors
osman.saatci@gmail.com
Keywords
C3 glomerulopathy, complement dysregulation, drusen, kidney transplantation, multimodal imagingAbstract
Introduction: C3 glomerulopathy (C3G) is a rare complement-mediated renal disorder caused by dysregulation of the alternative complement pathway. Retinal drusen-like deposits may occur as an extra-renal manifestation.
Case description: A 34-year-old woman with a history of childhood-onset nephrotic syndrome was later classified as having C3G. She underwent living-donor kidney transplantation four years earlier due to end-stage renal disease. She was examined as she was experiencing bilateral blurry vision of long duration and left metamorphopsia. Best-corrected visual acuity was 20/20 in the right eye and 20/40 in the left eye. Fundus examination showed widespread bilateral yellowish drusenoid deposits involving the macula and mid-peripheral retina. Spectral-domain optical coherence tomography demonstrated multiple subretinal pigment epithelium elevations and irregularity of the RPE-Bruch’s membrane complex, while fundus autofluorescence showed mixed hyper- and hypoautofluorescent changes. Renal biopsy material demonstrated intense C3c deposition along glomerular capillary walls with negative immunoglobulin and C1q staining.
Discussion: The shared susceptibility of the glomerular filtration barrier and the RPE-Bruch’s membrane complex to complement-mediated injury may explain this renal-retinal association. Retinal manifestations may remain unrecognised for years, even in kidney transplant recipients.
Conclusion: Clinicians caring for patients with longstanding C3G should be aware of possible ocular involvement. Multimodal retinal imaging can disclose retinal lesions and help clinicians to evaluate vision-threatening complications.
References
- Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, et al. C3 glomerulopathy: consensus report. Kidney Int. 2013;84(6):1079-89. doi: 10.1038/ki.2013.377.
- Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6:494–499. doi: 10.1038/nrneph.2010.85.
- Savige J, Amos L, Ierino F, Mack HG, Symons RC, Hughes P, et al. Retinal disease in the C3 glomerulopathies and the risk of impaired vision. Ophthalmic Genet. 2016;37:369–376. doi: 10.3109/13816810.2015.1101777.
- Kheir V, Dirani A, Halfon M, Venetz JP, Halabi G, Guex-Crosier Y. Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature. BMC Ophthalmol. 2017;17:207. doi: 10.1186/s12886-017-0602-4.
- Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–732. doi: 10.1016/s1350-9462(01)00010-6.
- Cunningham A, Kotagiri A. A long history of dense deposit disease. BMC Ophthalmol. 2018;18:228. doi: 10.1186/s12886-018-0853-8.
- McCarney J, Curran K, Peto T, Silvestri G, Cushley LN. The Retinal Complications of C3 Dense Deposit Disease: A Scoping Review. Vision (Basel). 2025;9(3):64. doi: 10.3390/vision9030064.
- Inanc M, Tekin K, Sekeroglu MA. Dense deposit disease complicated with choroidal neovascularization. Eye. 2025;39:1–3. doi: 10.1038/s41433-024-03534-y.
- Burgić SS, Grujičić M, Smoljanović-Skočić S, Markić B, Vukojević Z. Retinal involvement in biopsy-proven dense deposit disease: a single-centre retrospective observational study. Scripta Medica. 2026;57:757–767. doi: 10.5937/scriptamed57-69637.
- McAvoy CE, Silvestri G. Retinal changes associated with type 2 glomerulonephritis. Eye (Lond). 2005;19:985–989. doi: 10.1038/sj.eye.6701697.
